← Back to patent-cliff list
CAS 96-23-1
1,3-dichloropropan-2-olGlycerol-alpha,gamma-dichlorohydrin
Codes: SEVE-009, Mosapride Citrate-025
Application context (from source-drug indications)
HyperphosphataemiaSevelamer CarbonateChronic renal impairmentSevelamer CarbonateNephropathySevelamer CarbonateEnd-stage renal diseaseSevelamer CarbonateRenal impairmentSevelamer CarbonateHyperparathyroidismSevelamer CarbonateGastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sevelamer Carbonate | Tier B — Position early | - |
| Mosapride Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-methylbutan-1-amine hydrochloride(1:x)→5-((3-((4-(aminomethyl)-2-methylhexyl)amino)-2-hydroxypropyl)amino)-2-ethyl-4-methylpentan-1-aminium chloride→prop-2-en-1-amine hydrochloride→1,3-dichloropropan-2-ol
[4-(4-Fluorobenzyl)-2-morpholinyl]methylamine→2-Hydroxyethylamine→2-[[(4-Fluorophenyl)methyl]amino]ethan-1-ol→1,3-Dihydro-1,3-dioxoisoindole potassium salt→Glycerol-alpha,gamma-dichlorohydrin→N-(3-Chloro-2-hydroxypropyl)-phthalimide→2-(3-[[(4-Fluorophenyl)methyl](2-hydroxyethyl)amino]-2-hydroxypropyl)-1H-isoindole-1,3(2H)-dione→2-[2-Hydroxy-3-[(2-hydroxyethyl)amino]propyl]-1H-isoindole-1,3(2H)-dione→Morpholin-2-ylmethanamine→alpha-Chloro-4-fluorotoluene
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.